GlassScriptPhysician profile
Shahid Khan
NPI 1801050679
$7,684.74
in general payments reported to CMS, 2019-2025
19 companies · $1,856 in 2025
The $1,856 reported for 2025 was more than what 82% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,152 · 2020: $639 · 2021: $688 · 2022: $1,675 · 2023: $1,193 · 2024: $480 · 2025: $1,856.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,274 · Food and Beverage: $1,256.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,273.51 |
| Food and Beverage | $1,256.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,472.13 | 2019-2022 | |
| Edwards Lifesciences Corporation | $1,736.92 | 2021-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Penumbra, INC. | $1,713.77 | 2025 | Indigo System |
| Medtronic, INC. | $587.03 | 2021-2024 | Micra |
| Medtronic Vascular, INC. | $268.95 | 2019 | |
| Abiomed | $166.24 | 2019 | |
| Boston Scientific Corporation | $158.04 | 2019-2025 | Watchman Flx |
| Astrazeneca Pharmaceuticals LP | $127.95 | 2019-2024 | Farxiga |
| Novartis Pharmaceuticals Corporation | $122.83 | 2022-2024 | |
| Amgen INC. | $92.98 | 2020-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $92.80 | 2019-2022 | |
| Alnylam Pharmaceuticals INC. | $27.50 | 2019 | |
| Pfizer INC. | $26.92 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $25.45 | 2025 | Opsumit, Uptravi |
| Terumo Medical Corporation | $17.19 | 2023 | Glidesheath Slender |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $16.36 | 2020 | |
| Cardiovascular Systems INC. | $12.96 | 2022 | |
| Novo Nordisk INC | $12.71 | 2022 | |
| Z-Medica, LLC | $6.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shahid Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.